This work presents the gas separation evaluation of 6FDA-DAM:DABA (3:1) co-polyimide and its enhanced mixed matrix membranes (MMMs) with graphene oxide (GO) and ZIF-8 (particle size of <40 nm). The 6FDA-copolyimide was obtained through two-stage poly-condensation polymerization, while the ZIF-8 nanoparticles were synthesized using the dry and wet method. The MMMs were preliminarily prepared with 1–4 wt.% GO and 5–15 wt.% ZIF-8 filler loading independently. Based on the best performing GO MMM, the study proceeded with making MMMs based on the mixtures of GO and ZIF-8 with a fixed 1 wt.% GO content (related to the polymer matrix) and varied ZIF-8 loadings. All the materials were characterized thoroughly using TGA, FTIR, XRD, and FESEM. The gas separation was measured with 50:50 vol.% CO₂:CH₄ binary mixture at 2 bar feed pressure and 25 °C. The pristine 6FDA-copolyimide showed CO₂ permeability (P_CO2) of 147 Barrer and CO₂/CH₄ selectivity (α_CO2/CH4) of 47.5. At the optimum GO loading (1 wt.%), the P_CO2 and α_CO2/CH4 were improved by 22% and 7%, respectively. A combination of GO (1 wt.%)/ZIF-8 fillers tremendously improves its P_CO2; by 990% for GO/ZIF-8 (5 wt.%) and 1.124% for GO/ZIF-8 (10 wt.%). Regrettably, the MMMs lost their selectivity by 16–55% due to the non-selective filler-polymer interfacial voids. However, the hybrid MMM performances still resided close to the 2019 upper bound and showed good performance stability when tested at different feed pressure conditions.

Superparamagnetic iron oxide nanoparticles (SPIO-NPs) have great potential to be used in different pharmaceutical applications, due to their unique and versatile physical and chemical properties. The aim of this study was to quantify in vitro cytotoxicity of dextran 70,000-coated SPIO-NPs labelled/unlabelled with rhodamine 123, in C6 glioma cells and primary hippocampal neural cells. In addition, we analyzed the in vitro and in vivo cellular uptake of labelled SPIO-NPs. The nanoparticles, with average size of 10–50 nm and polydispersity index of 0.37, were synthesized using Massart’s co-precipitation method. The concentration-dependent cytotoxicity was quantified by using tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). Intracellular localization of SPIO-NPs was detected by confocal laser microscopy. In vivo confocal neuroimaging (ICON) was performed on male Wistar rats after intravitreal injection followed by ex vivo retina whole mount analysis. When used for in vitro testing concentrations in the range of diagnostic and therapeutic dosages, SPIO-NPs proved to be non-cytotoxic on C6 glioma cells for up to 24 h incubation time. The hippocampal cell culture also did not show impaired viability at low doses after 24 h incubation. Our results indicate that our dextran-coated SPIO-NPs have the potential for in vivo drug delivery applications.